CV

Carmen Vigo-Pelfrey

EP Elan Pharmaceuticals: 5 patents #59 of 269Top 25%
EL Eli Lilly: 4 patents #824 of 2,858Top 30%
AN Athena Neurosciences: 2 patents #39 of 81Top 50%
BH Brigham and Women's Hospital: 2 patents #490 of 1,764Top 30%
📍 Mountain View, CA: #2,615 of 11,022 inventorsTop 25%
🗺 California: #73,997 of 386,348 inventorsTop 20%
Overall (All Time): #656,881 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
7811769 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau Peter A. Seubert, Dale B. Schenk, Robin Barbour 2010-10-12
7700309 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau Peter A. Seubert, Dale B. Shenk, Robin Barbour 2010-04-20
7427392 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau Peter A. Seubert, Dale B. Schenk, Robin Barbour 2008-09-23
6284221 Method for identifying .beta.-amyloid peptide production inhibitors Dale B. Schenk, Michael Schlossmacher, Dennis J. Selkoe, Peter A. Seubert 2001-09-04
6114133 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-.beta. peptide (x-.gtoreq.41) Peter A. Seubert, Dale B. Schenk, Robin Barbour 2000-09-05
5880116 Use of celastrol to treat alzheimer's disease 1999-03-09
5837672 Methods and compositions for the detection of soluble .beta.-amyloid peptide Dale B. Schenk, Michael Schlossmacher, Dennis J. Selkoe, Peter A. Seubert 1998-11-17
5593846 Methods for the detection of soluble .beta.-amyloid peptide Dale B. Schenk, Peter A. Seubert 1997-01-14